0000912282-23-000523.txt : 20231128
0000912282-23-000523.hdr.sgml : 20231128
20231128115140
ACCESSION NUMBER: 0000912282-23-000523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231121
FILED AS OF DATE: 20231128
DATE AS OF CHANGE: 20231128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VITA NICHOLAS
CENTRAL INDEX KEY: 0001907623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56294
FILM NUMBER: 231443311
MAIL ADDRESS:
STREET 1: C/O COLUMBIA CARE INC.
STREET 2: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cannabist Co Holdings Inc.
CENTRAL INDEX KEY: 0001776738
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100]
IRS NUMBER: 981488978
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2125543424
MAIL ADDRESS:
STREET 1: 680 FIFTH AVENUE, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Columbia Care Inc.
DATE OF NAME CHANGE: 20190514
4
1
form4.xml
X0508
4
2023-11-21
0001776738
Cannabist Co Holdings Inc.
CBSTF
0001907623
VITA NICHOLAS
C/O THE CANNABIST COMPANY HOLDINGS INC.
680 FIFTH AVENUE, 24TH FLOOR
NEW YORK
NY
10019
true
true
Chief Executive Officer
false
Common Shares
2023-11-21
4
S
0
100000
0.3468
D
21327075
I
Held by Vita Holdings LLC
Common Shares
2023-11-22
4
S
0
50000
0.3607
D
21277075
I
Held by Vita Holdings LLC
Common Shares
2023-11-27
4
S
0
50000
0.352
D
21227075
I
Held by Vita Holdings LLC
Common Shares
2023-11-27
4
S
0
50000
0.3557
D
21177075
I
Held by Vita Holdings LLC
Common Shares
618950
D
The sales price reported above was converted from the Canadian sales price of C$0.475 using an exchange rate of C$1.3698 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.495 using an exchange rate of C$1.3723 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.48 using an exchange rate of C$1.3635 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.485 using an exchange rate of C$1.3635 = US$1.00.
Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes.
/s/ Nicholas Vita
2023-11-28